Xtant Medical Holdings (XTNT) Tops Q3 EPS by 8c

Xtant Medical Holdings (NYSE: XTNT) reported Q3 EPS of $0.07, $0.08 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $25.02 million versus the consensus estimate of $18.9 million.

For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Xtant Medical (XTNT) PT Lowered to $0.60 at Craig-Hallum